Arrhythmia & Electrophysiology Review最新文献

3D Anatomy of the Atrioventricular Conduction Axis Reconstructed Relative to Gross Anatomical Landmarks Using Hierarchical Phase-contrast Tomography. 使用分层相衬断层扫描重建相对于大体解剖标志的房室传导轴三维解剖。

IF 2.6

Arrhythmia & Electrophysiology Review Pub Date : 2025-06-04 eCollection Date: 2025-01-01 DOI: 10.15420/aer.2025.18

Justin T Tretter, Robert H Anderson, Kenneth A Ellenbogen, ShlomoA Ben-Haim

引用次数: 0

Fascicular and Papillary Muscle Arrhythmias in the Structurally Normal Heart. 结构正常心脏的束状肌和乳头状肌心律失常。

IF 2.6

Arrhythmia & Electrophysiology Review Pub Date : 2025-05-19 eCollection Date: 2025-01-01 DOI: 10.15420/aer.2024.54

Travis D Richardson, Roy M John

引用次数: 0

The Management of Obesity Before Catheter Ablation of AF: The Missing Piece? 房颤导管消融前肥胖的处理：缺失的部分？

IF 2.6

Arrhythmia & Electrophysiology Review Pub Date : 2025-05-19 eCollection Date: 2025-01-01 DOI: 10.15420/aer.2024.45

Kyaw Z Win, Matthew J Armstrong, Richard P Steeds, Manish Kalla

{"title":"The Management of Obesity Before Catheter Ablation of AF: The Missing Piece?","authors":"Kyaw Z Win, Matthew J Armstrong, Richard P Steeds, Manish Kalla","doi":"10.15420/aer.2024.45","DOIUrl":"10.15420/aer.2024.45","url":null,"abstract":"Obesity independently increases AF risk and negatively affects the outcomes of catheter ablation. This review examines the relationship between obesity and AF, focusing on structural and electrical remodelling. Multiple studies demonstrate worse ablation outcomes in patients with obesity. Pre-ablation weight loss improves outcomes and maintaining weight loss post-ablation is equally important. Risk factor modification programmes show promise, however they require a large investment in resources. Less intensive strategies focusing on diet and exercise have shown mixed results. Glucagon-like peptide-1 receptor agonists have been identified as potential adjunct therapies. They have multiple effects, including preferential reduction of epicardial adipose tissue and an anti-inflammatory action. Further research is needed to establish their efficacy in improving ablation outcomes. This review highlights the importance of weight management in AF treatment and suggests potential monitoring strategies using cardiac imaging. Future studies may shift the paradigm for the management of AF patients with obesity who are undergoing ablation.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":"14 ","pages":"e09"},"PeriodicalIF":2.6,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12127968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144207440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Electroanatomic Mapping of the Atrioventricular Node and Right Inferior Nodal Extension: Insights from a Case Series. 房室结和右下结延伸的电解剖定位：来自一个病例系列的见解。

IF 2.6

Arrhythmia & Electrophysiology Review Pub Date : 2025-04-28 eCollection Date: 2025-01-01 DOI: 10.15420/aer.2024.34

George Katritsis, George Stavropoulos, Nikolaos Fragakis

引用次数: 0

Ten-year Follow-up Study of Patients with Persistent Atrial Fibrillation Treated by Combined Pulmonary Vein Isolation and Complex Fractionated Electrogram Ablation. 肺静脉隔离联合复合分割电消融术治疗持续性房颤10年随访研究。

IF 2.6

Arrhythmia & Electrophysiology Review Pub Date : 2025-02-28 eCollection Date: 2025-01-01 DOI: 10.15420/aer.2024.43

Kristian Wollner, Christian Tønseth, Eivind Solheim, Jian Chen

{"title":"Ten-year Follow-up Study of Patients with Persistent Atrial Fibrillation Treated by Combined Pulmonary Vein Isolation and Complex Fractionated Electrogram Ablation.","authors":"Kristian Wollner, Christian Tønseth, Eivind Solheim, Jian Chen","doi":"10.15420/aer.2024.43","DOIUrl":"10.15420/aer.2024.43","url":null,"abstract":"Aim: This study retrospectively investigated the clinical outcomes of patients with persistent AF treated with a combined approach of pulmonary vein isolation (PVI) and complex fractionated atrial electrogram (CFAE) ablation over a follow-up period of 10 years.Methods: A total of 73 patients with persistent and long-standing persistent AF who underwent combined pulmonary vein isolation and CFAE ablation in the first procedure were included. A complete CFAE mapping of the left atrium and coronary sinus was performed with a 3D mapping system. All CFAEs defined as electrograms with continuous activity or mean cycle length detected by the system of <80 ms were excluded. Patients were controlled regularly during the first year followed by annual control. Any documented atrial tachyarrhythmia (ATA) was regarded as a recurrence.Results: After index ablation, 18 (24.7%) were free of ATAs during 10-year follow-up. The proportion of atrial flutter (AFL) was 39.7%, with six typical AFL. A mean of 2.2 ± 1.2 ablation procedures were performed in each patient. After multiple procedures, 33 (45.2%) patients were free of ATA during the follow-up. The proportion of AFL was 23.2% with no typical AFL. Older age, female sex and a longer AF history were associated with ATA recurrence.Conclusion: A high recurrence rate of ATA was observed after index procedure of pulmonary vein isolation plus CFAE ablation in patients with persistent AF. No significant difference in freedom of ATA was found between persistent and long-standing persistent AF groups beyond 1 year. The incidence of postablation AFL was particularly high, even after multiple ablations.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":"14 ","pages":"e07"},"PeriodicalIF":2.6,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934120/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143708177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Management of Cardiac Rhythm Disorders in Cardio-oncology. 心脏肿瘤学中心律失常的管理。

IF 2.6

Arrhythmia & Electrophysiology Review Pub Date : 2025-02-20 eCollection Date: 2025-01-01 DOI: 10.15420/aer.2024.20

Letizia Rosa Romano, Alberto Polimeni, Ciro Indolfi, Antonio Curcio

{"title":"Management of Cardiac Rhythm Disorders in Cardio-oncology.","authors":"Letizia Rosa Romano, Alberto Polimeni, Ciro Indolfi, Antonio Curcio","doi":"10.15420/aer.2024.20","DOIUrl":"10.15420/aer.2024.20","url":null,"abstract":"Arrhythmias and cancer are two pathological conditions that often coexist due to a patient's pre-existing comorbidities, or toxicity linked to anti-neoplastic drugs, and both are often characterised by poor prognosis. Cardio-oncology is a new interdisciplinary field that focuses on the cardiovascular health of cancer patients, especially those undergoing cancer treatment. Furthermore, cardiotoxicity can cause arrhythmias through primary and secondary mechanisms. Chemotherapy drugs have been shown to directly affect molecular pathways associated with arrhythmia development, as well as indirectly through mechanisms involving ischaemia or inflammatory injury to the heart. Understanding how to prevent and to treat these electrophysiological issues in cancer is an important challenge for cardio-oncologists. This review explores the intersection between cardio-oncology and electrophysiology, the various cardiac cell types implicated in the development of arrhythmias during cancer, the interplay between arrhythmias and cancer pathogenesis, and the need for the implantation of electronic devices along with their associated risks.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":"14 ","pages":"e05"},"PeriodicalIF":2.6,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11904418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143623258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

His Bundle Pacing in the Era of Left Bundle Branch Pacing. 他在左束分支节奏时代的束式节奏。

IF 2.6

Arrhythmia & Electrophysiology Review Pub Date : 2025-02-20 eCollection Date: 2025-01-01 DOI: 10.15420/aer.2024.31

Marek Jastrzębski, Weijian Huang, Pablo Moriña Vazquez, Pugazhendhi Vijayaraman

引用次数: 0

Conduction System Pacing for CRT: A Physiological Alternative. 传导系统起搏：一种生理选择。

IF 2.6

Arrhythmia & Electrophysiology Review Pub Date : 2025-02-18 eCollection Date: 2025-01-01 DOI: 10.15420/aer.2024.10

Bengt Herweg, Mishal Mumtaz, Pugazhendhi Vijayaraman

引用次数: 0

Temperature-controlled Ablation Versus Conventional Ablation for Pulmonary Vein Isolation in the Treatment of AF: A Systematic Review and Meta-Analysis. 温度控制消融与常规消融肺静脉隔离治疗房颤：系统回顾和荟萃分析。

IF 2.6

Arrhythmia & Electrophysiology Review Pub Date : 2025-01-30 eCollection Date: 2025-01-01 DOI: 10.15420/aer.2024.41

Benjamin Clay, Balamrit S Sokhal, Sarah Zeriouh, Neil T Srinivasan, Parag R Gajendragadkar, Claire A Martin

{"title":"Temperature-controlled Ablation Versus Conventional Ablation for Pulmonary Vein Isolation in the Treatment of AF: A Systematic Review and Meta-Analysis.","authors":"Benjamin Clay, Balamrit S Sokhal, Sarah Zeriouh, Neil T Srinivasan, Parag R Gajendragadkar, Claire A Martin","doi":"10.15420/aer.2024.41","DOIUrl":"10.15420/aer.2024.41","url":null,"abstract":"Background: This study compared the efficacy and safety of temperature-controlled and conventional contact-force-sensing radiofrequency ablation catheters for pulmonary vein isolation (PVI) in AF.Methods: Seven studies (1,138 patients) were included. Randomised controlled trials and observational (single-arm and two-arm) studies that reported freedom from AF ≥3 months after PVI with temperature-controlled radiofrequency ablation catheters (Biosense Webster QDOT MICRO operating in QMODE or Medtronic DiamondTemp) were included.Results: Freedom from AF at a mean (± SD) follow-up of 9.0 ± 3.6 months did not differ significantly between temperature-controlled and conventional ablation (OR 1.22; 95% CI [-0.79, 1.64]; p=0.24). Total procedure duration (-13.5 minutes; 95% CI [-17.1, -10.0 minutes]; p<0.001) and total ablation duration (-8.9 min; 95% CI [-10.3, -7.5 min]; p<0.01) were significantly shorter for temperature-controlled ablation. There were no significant differences between temperature-controlled and conventional ablation in either the aggregated rates of procedural complications (OR 0.69; 95% CI [-0.15, 1.54]; p=0.11) or in the rate of any individual complication.Conclusion: Temperature-controlled ablation was found to be at least non-inferior to conventional ablation in all measures of efficacy and safety. Further randomised controlled trials are warranted to evaluate long-term rates of freedom from AF and patient comfort.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":"14 ","pages":"e03"},"PeriodicalIF":2.6,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11865669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143522574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Predictors of Improvement in Left Ventricular Systolic Dysfunction in Patients with Atrial Fibrillation Undergoing Catheter Ablation: Systematic Review. 房颤患者行导管消融后左室收缩功能障碍改善的预测因素：系统综述。

IF 2.6

Arrhythmia & Electrophysiology Review Pub Date : 2025-01-30 eCollection Date: 2025-01-01 DOI: 10.15420/aer.2024.24

Nikhil Ahluwalia, Ahmed Hussain, Rui Providencia, Richard J Schilling

{"title":"Predictors of Improvement in Left Ventricular Systolic Dysfunction in Patients with Atrial Fibrillation Undergoing Catheter Ablation: Systematic Review.","authors":"Nikhil Ahluwalia, Ahmed Hussain, Rui Providencia, Richard J Schilling","doi":"10.15420/aer.2024.24","DOIUrl":"10.15420/aer.2024.24","url":null,"abstract":"Background: Left ventricular systolic dysfunction (LVSD) can improve after catheter ablation (CA) in many patients with AF. However, prospective prediction of response can be challenging. The aim of this study was, therefore, to perform a systematic literature review of features associated with improvement in left ventricular ejection fraction (LVEF) in patients with AF and LVSD undergoing first CA.Method: Systematic search of Ovid MEDLINE, Embase and Cochrane Library databases up to 24 January 2024, for studies involving adult patients with LVSD receiving treatment for AF. The focus was on research articles and clinical trials reporting features associated with changes in LVEF following CA. The review followed PRISMA guidelines.Results: A total of 789 unique articles were reviewed and 20 were included in the systematic review. Sixty-nine per cent (range, 54-79%) of included patients met the criteria for responder status, which were based on LVEF improvement (usually an increase in LVEF >10% or to >50% at follow-up). Baseline surrogates of myocardial fibrosis on MRI (R2=-0.67), electroanatomical mapping (R2=-0.93) and biochemical surrogates have shown the strongest association with LVEF change. Left atrium and LV chamber size, diastolic dysfunction ECGbased parameters and a known heart failure aetiology have shown prognostic value independently and in combination.Discussion: Imaging, clinical and ECG-based surrogates of LV fibrosis may be pre-CA markers of LVEF improvement in patients with AF and LVSD. However, the confounding effect of procedural outcomes should be considered. A composite risk stratification tool would have clinical utility in risk stratification and patient selection; however, prospective studies are needed.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":"14 ","pages":"e02"},"PeriodicalIF":2.6,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11865674/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143522573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0